Brainsway Ltd
TASE:BWAY
Intrinsic Value
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimula... [ Read More ]
The intrinsic value of one BWAY stock under the Base Case scenario is 598.25 ILS. Compared to the current market price of 1 062 ILS, Brainsway Ltd is Overvalued by 44%.
Valuation Backtest
Brainsway Ltd
Run backtest to discover the historical profit from buying and selling BWAY stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Brainsway Ltd
Current Assets | 55.5m |
Cash & Short-Term Investments | 46.3m |
Receivables | 3.8m |
Other Current Assets | 5.4m |
Non-Current Assets | 7.5m |
Long-Term Investments | 1.7m |
PP&E | 5.8m |
Current Liabilities | 9.8m |
Accounts Payable | 6.2m |
Other Current Liabilities | 3.5m |
Non-Current Liabilities | 11.6m |
Other Non-Current Liabilities | 11.6m |
Earnings Waterfall
Brainsway Ltd
Revenue
|
31.8m
USD
|
Cost of Revenue
|
-8.3m
USD
|
Gross Profit
|
23.5m
USD
|
Operating Expenses
|
-28.4m
USD
|
Operating Income
|
-5m
USD
|
Other Expenses
|
762k
USD
|
Net Income
|
-4.2m
USD
|
Free Cash Flow Analysis
Brainsway Ltd
BWAY Profitability Score
Profitability Due Diligence
Brainsway Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Brainsway Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
BWAY Solvency Score
Solvency Due Diligence
Brainsway Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Score
Brainsway Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BWAY Price Targets Summary
Brainsway Ltd
Shareholder Return
BWAY Price
Brainsway Ltd
Average Annual Return | -26.69% |
Standard Deviation of Annual Returns | 28.29% |
Max Drawdown | -87% |
Market Capitalization | 348.9m ILS |
Shares Outstanding | 328 553 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Contact
IPO
Employees
Officers
The intrinsic value of one BWAY stock under the Base Case scenario is 598.25 ILS.
Compared to the current market price of 1 062 ILS, Brainsway Ltd is Overvalued by 44%.